Use of PRP, Stem Cells and Prolotherapy In Osteoarthritis
DIFFICULT SCENARIOS IN BIOLOGIC USE
TARGETED SYNTHETIC DMARDS VS. BIOLOGICS IN THE MANAGEMENT OF RHEUMATOID ARTHRITIS: ARE TARGETED SYNTHETICS BEGINNING TO DOMINATE THE LANDSCAPE?
AXIAL SPONDYLOARTHRITIS. DIFFERENTIATING RADIOGRAPHIC (ANKYLOSING SPONDYLITIS) FROM NON-RADIOGRAPHIC DISEASE AND MANAGEMENT OPTIONS: SHOULD WE BE TREATING AXIAL SPONDYLOARTHRITIS EARLIER?
THE MICROBIOME AND INFLAMMATORY ARTHRITIS
UNDERSTANDING MTX: HOW TO MANAGE THE DRUG INFORMED BY SCIENCE
INFLAMMATORY EYE DISEASE (UVEITIS) FOR THE RHEUMATOLOGIST
TREATMENT PRIORITIES AND SEQUENCING OF DMARD & BIOLOGIC USE